Ask AI

Momentum in mTNBC: Clinical Integration of TROP2 ADCs for Patients Who Are Not Candidates for Immunotherapy

Expand your knowledge of current and emerging clinical evidence for TROP2-directed ADCs in patients with TNBC who are not eligible for immunotherapy, individualize treatment selection and sequencing strategies to optimize patient outcomes through a certified interactive case challenge, expert-authored ClinicalThought commentary, and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

  • Live Event
    Momentum in mTNBC: Clinical Integration of TROP2 ADCs for Patients Who Are Not Candidates for Immunotherapy
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.